Those were the topics as our senior management took part in a number of plenary sessions at the annual convention of the Biotechnology Industry Organization (BIO 2005) in Philadelphia, USA. The conference took place 19-22 June. 

Below you will find links to short summaries of the plenary sessions where AstraZeneca contributed.

Session title	AstraZeneca contributor
Saving the world:  The future of global drug development	John Patterson Global Head Drug Development
The pipeline challenge	Jan Lundberg Global Head Discovery Research
Health care in the 21st century:  A discussion of the future of health-care quality and the role of the pharmaceutical and biotech industries	David Brennan (chair) President & CEO AstraZeneca USA
Thinking A HEAD in neuroscience	Frank Yocca Vice President CNS Research
Is bigger better? The role of large-molecule cancer research in Big Pharma	Louise Grochow (chair) Product Medical Director

We want to network and discuss with potential partners in a constructive and efficient way. Therefore we have chosen to be a main sponsorof the world’s largest biotech meeting.

This page was last updated 12 July 2005